Vincerx Pharma Inc. (VINCW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vincerx Pharma Inc.

    NASDAQ: VINCW · Real-Time Price · USD
    1.61
    -0.42 (-20.69%)
    At close: May 05, 2021, 9:12 PM

    Vincerx Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 915K 939K 340K
    Gross Profit
    		 n/a -915K -939K -340K
    Operating Income
    		 -31.46M -42.61M -73.57M -62.66M
    Interest Income
    		 472K 1.25M 664K n/a
    Pretax Income
    		 -30.07M -40.16M -65.37M -39.31M
    Net Income
    		 -30.07M -40.16M -57.16M -15.61M
    Selling & General & Admin
    		 15.98M 13.64M 18.95M 22.57M
    Research & Development
    		 15.49M 28.06M 52.15M 40.08M
    Other Expenses
    		 n/a n/a 1.24M -8K
    Operating Expenses
    		 31.46M 41.69M 71.11M 62.66M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 42.61M 71.11M 62.66M
    Income Tax Expense
    		 n/a n/a -8.21M -23.7M
    Shares Outstanding (Basic)
    		 5.23M 5.87M 5.8M 4.74M
    Shares Outstanding (Diluted)
    		 5.23M 5.87M 5.8M 4.74M
    EPS (Basic)
    		 -5.75 -6.84 -10.86 -8.3
    EPS (Diluted)
    		 -5.75 -6.84 -10.86 -8.3
    EBITDA
    		 -31.46M -42.56M -68.67M -62.66M
    EBIT
    		 n/a -40.16M -68.72M -62.66M
    Depreciation & Amortization
    		 n/a 915K 939K 340K

    Add to Watchlist